Accumed Inc.

News & Analysis

accumed inc. - All News and Analysis

• Electrical stimulation: Accumed Medical

  - 2005-08-01

  The ETPS 1000 is a hand-field, portable device that locates acupuncture and trigger points and stimulates with concentrated direct current impulses to relieve pain. The device has received FDA approval for treatment of chronic intractable pain. Circle No 102 on the Reader Service Card or visit www.apta.org/adinfo [ILLUSTRATION...

  Tags: Accumed Inc.

• Grants helped turn prototype into product.(News)(Accumed Systems Inc., Small Business Innovation Research grants)

  - 2004-12-20

  Byline: Sheena Harrison Accumed Systems Inc. was stuck. Management knew the Ann Arbor-based medical devices company had the potential to commercialize its heart catheter product. But it needed money. And licensing royalties from a high-pressure inflation device used for balloon angioplasty...

  Tags: Accumed Inc.

• Accumed Systems Awarded Million-Dollar Grant for Development of Diagnostic Catheter System

  - 2004-11-17

  ANN ARBOR, Mich. -- Accumed Systems, Inc. recently was awarded a two-year, $1.2 million Phase 2 SBIR Small Business Innovation Research grant from the National Heart, Lung, and Blood Institute NHLBI of the National Institutes of Health NIH. Accumed will use the money to complete product development of a...

  Tags: Accumed Inc.

• AccuMed Chooses ORION@Pharma to Streamline Supply Chain; ICICI Infotech Selected by Private Label Drug Manufacturer for Proven Expertise

  - 2004-09-29

  EDISON, N.J. -- ICICI Infotech (www.icici-infotech.com), a global IT services and solutions provider, has announced that its second generation ERP product, ORION@Pharma, has been selected by AccuMed Inc. to streamline its supply chain, from manufacturing to retailers.

  Tags: Streamline, supply chain

• AccuMed gets clean bill of health

  - 2003-09-01

  A 2002 FDA audit of AccuMed's Lawrenceville, NJ, plant revealed that GMP faults from the previous year had been adequately rectified, according to documents from the inspection, which was conducted by investigators Marea Harmon and Margaret Sands of the New Jersey District. The previous inspection of the OTC pharmaceutical...

  Tags: Accumed Inc.

• Accumed Systems, Inc. Launches AccuGage Vessel Caliper for Intravascular Length Measurements

  - 2001-10-25

  Business Editors & Health/Medical Writers ANN ARBOR, Mich.--BW HealthWire--Oct. 25, 2001 Accumed Systems, Inc. announces the launch of a new device to measure intravascular length without the expense of a highly technical visual system. The device is compatible with standard catheters, guidewires and connectors, and can measure up...

  Tags: Accumed Inc.

• Accumed Systems, Inc. Adds New President

  - 2001-10-25

  Business Editors & Health/Medical Writers ANN ARBOR, Mich.--BW HealthWire--Oct 25, 2001 The Board of Directors of Accumed Systems, Inc. is pleased to announce the addition of James M. Koert, as the new president for the company, effective October, 2001. "Accumed is entering a new phase of product...

  Tags: Accumed Inc.

• Accumed Systems, Inc. Receives Small Business Innovation Research Award From National Heart, Lung and Blood Institute

  - 2001-08-20

  Business Editors, Health/Medical Writers ANN ARBOR, Mich.--BW HealthWire--Aug. 20, 2001 Accumed Systems, Inc. has received a Small Business Innovation Research Phase I grant from the National Heart, Lung and Blood Institute. Proceeds from the $100,000 grant will be used to support development of a sensor-based catheter that...

  Tags: Accumed Inc.

• Accumed Systems Receives Investment From Michigan Life Sciences Corridor

  - 2001-06-25

  Business Editors & Health/Medical Writers ANN ARBOR, Mich.--BW HealthWire--June 25, 2001 Accumed Systems, Inc. has received a $1.29 million investment from the Michigan Life Sciences Corridor MLSC Fund. Proceeds from the investment will be used to develop a catheter to thermally classify atherosclerotic plaque. Thomas Haddock, Ph.D.,...

  Tags: Accumed Inc.

• Accumed and Ampersand modify prior cancer screening patent license agreement.

  - 2000-04-01

  AccuMed International, Inc (Chicago, IL; 312-642-9200) and Ampersand Medical Corporation announced that they have revised the prior agreement and have settled all past disputes between the two companies involving a prior license agreement. The new patent and technology license agreement provides Ampersand Medical...

  Tags: Accumed Inc.